Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.1 - 1
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.01
General Information
Version
1.0
Revision date
2025-02-28
Product name
Medisense Brand Glucose & Ketone Control Solutions Hi / Mid / Lo
1.2.1 Relevant identified uses
Reagent
Emergency telephone
1(800) 424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Abbott Diabetes Care Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
Abbott.SDS@abbott.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07
Signal word
Warning
Contains
Sodium hydroxide
Hazard statements
H315 - Causes skin irritation. H319 - Causes serious eye irritation.
Precautionary statements
P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P332+P313 - If skin irritation occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse.
Supplemental label elements
EUH208 - Contains Proclin 300 (55965-84-9). May produce an allergic reaction.
2.3 Other hazards
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Full text of H-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available